NUCLEIC ACID CONTAINING OR CODING HISTONE "STEM-LOOP" STRUCTURE AND SEQUENCE OF POLY (A) OR POLYADENYLATION SIGNAL, TO INCREASE EXPRESSION OF CODED PATHOGENIC ANTIGEN Russian patent published in 2017 - IPC C12N15/68 A61K39/00 C12N15/117 

Abstract RU 2639528 C2

FIELD: biotechnology.

SUBSTANCE: nucleic acid encoding a protein that is a pathogenic antigen, a histone stem-loop structure and a poly (A) or polyadenylation signal, a kit and a pharmaceutical composition containing one or more of said nucleic acid for treatment of an infectious disease, and a method for enhancement of expression of the encoded protein and the use of the said nucleic acid, kit or composition to enhance the encoded protein expression. The structure of the proposed nucleic acid, consisting of a combination of the poly (A) sequence or the polyadenylation signal elements in conjunction with the histone stem-loop structure, provides an increase in protein expression significantly above the level observed when using these elements separately.

EFFECT: proposed group of inventions can be used in medicine for treatment of infectious diseases.

26 cl, 24 dwg, 15 tbl, 11 ex

Similar patents RU2639528C2

Title Year Author Number
NUCLEIC ACID CONTAINING OR CODING HYSTON "STEM-LOOP" STRUCTURE AND SEQUENCE OF POLY (A) OR POLYADENYLATION SIGNAL, TO INCREASE EXPRESSION OF CODED THERAPEUTIC PROTEIN 2013
  • Tess Andreas
  • Shlake Tomas
  • Probst Jokhen
RU2634391C2
NUCLEIC ACID CONTAINING OR ENCODING HISTONE "STEM-LOOP"-TYPE STRUCTURE AND POLY(A)-SEQUENCE OF SIGNAL OF POLYADENILATION FOR INCREASE IN EXPRESSION OF ENCODED PROTEIN 2011
  • Tess Andreas
  • Shlake Tomas
  • Probst Jokhen
RU2583295C2
NUCLEIC ACID COMPRISING OR CODING HISTONE STEM-LOOP AND POLY(A)-SEQUENCE OR POLYADENYLATION SIGNAL FOR INCREASING EXPRESSION OF ENCODED TUMOUR ANTIGEN 2013
  • Tess Andreas
  • Shlake Tomas
  • Probst Jokhen
RU2650795C2
NUCLEIC ACID CONTAINING OR CODING HISTONE STRUCTURE OF STEM-LOOP TYPE AND POLY(A)-SEQUENCE OR POLYADENYLATION SIGNAL FOR INCREASING EXPRESSION OF ENCODED TUMOUR ANTIGEN 2013
  • Tess Andreas
  • Shlake Tomas
  • Probst Jokhen
RU2718577C2
PRIME-BOOST MODES INVOLVING INTRODUCTION OF AT LEAST ONE MRNA STRUCTURE 2016
  • Fotin-Mlechek Mariola
  • Probst Jokhen
RU2742993C2
ARTIFICIAL MOLECULES OF NUCLEIC ACIDS FOR IMPROVED EXPRESSION OF PROTEINS AND PEPTIDES 2013
  • Tess Andreas
RU2750261C2
HYBRID CARRIERS FOR DELIVERY OF NUCLEIC ACIDS 2017
  • Baumkhof, Patrik
  • Tile-Zyus, Karolin
  • Rejman, Joanna
RU2751001C2
PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF POLYMER CARRIER AND CARRIED SUBSTANCE AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN 2013
  • Baumkhof Patrik
  • Kramps Tomas
  • Foss Zenke
  • Kallen Karl-Jozef
  • Fotin-Mlechek Mariola
RU2617058C2
ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN OR PEPTIDE EXPRESSION 2013
  • Tess Andreas
RU2658490C2
COMBINATION OF ANTI-CANCER RNA VACCINE AND PD-1 PATHWAY INHIBITOR AND ITS APPLICATION 2014
  • Fotin-Mlechek Mariola
  • Kallen Karl-Jozef
  • Probst Jokhen
RU2718988C2

RU 2 639 528 C2

Authors

Tess Andreas

Shlake Tomas

Probst Jokhen

Dates

2017-12-21Published

2013-02-15Filed